FDA Provides Update On Efforts To Modernize Its Technology And Data Collection
Executive Summary
After launching its Data Modernization Action Plan (DMAP) one year ago, and its Technology Modernization Action Plan (TMAP) three years ago, the US Food and Drug Administration has provided an update to its progress with “Modernization in Action.”
You may also be interested in...
Office of Digital Transformation’s 2022 Year In Review: The MAP To Success
The FDA’s Office of Digital Transformation published its first full-year report summarizing its 2022 accomplishments and future strategic priorities.
FDA Launches Digital Modernization Plan To Complement Its Technology Modernization Plan
Agency heads say the new plan will siphon and aggregate more data that could help the regulatory body make better and faster regulatory decisions.
FDA Unveils Technology Modernization Plan To Better Handle ‘Tsunami’ Of Incoming RWE Data
The US agency has introduced a new action plan geared toward handling an expected incoming storm of real world evidence (RWE) data that companies will be submitting to support future device and drug approvals.